Eradicating neurodegenerative diseases
Abyssinia Biologics has raised $750K in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Abyssinia Biologics's investors include Maine Technology Institute.
Abyssinia Biologics is headquartered in Boston, United States.
Eradicating neurodegenerative diseases
Abyssinia Biologics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Abyssinia Biologics — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/abyssinia-biologics. Accessed July 19, 2026.
VCBacked. (2024). Abyssinia Biologics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/abyssinia-biologics
{{cite web |title=Abyssinia Biologics — Funding & Investors |url=https://www.vcbacked.co/company/abyssinia-biologics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated